Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases
Margarita M. Ivanova, Erk Changsila, Chidima Iaonou, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210617-e0210617
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
The role of lysosomes in metabolic and autoimmune diseases
Frédéric Gros, Sylviane Muller
Nature Reviews Nephrology (2023) Vol. 19, Iss. 6, pp. 366-383
Closed Access | Times Cited: 74
MitophAging: Mitophagy in Aging and Disease
Daniela Bakula, Morten Scheibye‐Knudsen
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 118
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
Karolina M. Stępień, Federico Roncaroli, Nadia Turton, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2596-2596
Open Access | Times Cited: 78
Lipophagy and Lipolysis Status in Lipid Storage and Lipid Metabolism Diseases
Anna Kłoska, Magdalena Węsierska, Marcelina Malinowska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6113-6113
Open Access | Times Cited: 73
N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
Siddhee A. Sahasrabudhe, Márcia R. Terluk, Reena V. Kartha
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1316-1316
Open Access | Times Cited: 28
Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications
Hibba Kurdi, Lucia Lavalle, James Moon, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 10
Impaired autophagy: The collateral damage of lysosomal storage disorders
Rachel Myerowitz, Rosa Puertollano, Nina Raben
EBioMedicine (2020) Vol. 63, pp. 103166-103166
Open Access | Times Cited: 56
Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders
Alex E. Ryckman, Inka Brockhausen, Jagdeep S. Walia
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6881-6881
Open Access | Times Cited: 52
Gaucher disease – more than just a rare lipid storage disease
Jaehyeok Roh, Subbaya Subramanian, Neal J. Weinreb, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 4, pp. 499-518
Closed Access | Times Cited: 32
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
Eddie Pradas, Marta Martínez‐Vicente
Cells (2023) Vol. 12, Iss. 1, pp. 191-191
Open Access | Times Cited: 20
Autophagy in the retinal pigment epithelium: a new vision and future challenges
Daniela Intartaglia, Giuliana Giamundo, Iván Conte
FEBS Journal (2021) Vol. 289, Iss. 22, pp. 7199-7212
Open Access | Times Cited: 41
Fabry disease: Mechanism and therapeutics strategies
Xi Li, Xiangyi Ren, Yabing Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Fabry Disease and Central Nervous System Involvement: From Big to Small, from Brain to Synapse
Elisenda Cortès‐Saladelafont, Julián Fernández-Martín, Saida Ortolano
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5246-5246
Open Access | Times Cited: 13
Fabry Disease: Cardiac Implications and Molecular Mechanisms
David Weissman, Jan Dudek, Vasco Sequeira, et al.
Current Heart Failure Reports (2024) Vol. 21, Iss. 2, pp. 81-100
Open Access | Times Cited: 5
The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson’s therapeutics
Juan Carlos Rubilar, Tiago F. Outeiro, Andrés D. Klein
Brain (2024) Vol. 147, Iss. 8, pp. 2610-2620
Closed Access | Times Cited: 5
Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation
Justyna Okarmus, Helle Bogetofte, Sissel Ida Schmidt, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 39
Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases
Margarita M. Ivanova
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 1116-1116
Open Access | Times Cited: 37
Inflammation and Exosomes in Fabry Disease Pathogenesis
Bruna Coelho-Ribeiro, Helena Silva, Belém Sampaio‐Marques, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 654-654
Open Access | Times Cited: 4
Metabolic and proteomic profiles provide insights on mechanism of late onset Pompe disease
Yuxuan Lu, Jiayu Tian, Jianwen Deng, et al.
Molecular Genetics and Metabolism (2025) Vol. 144, Iss. 3, pp. 109045-109045
Closed Access
Unravelling a mechanistic link between mitophagy defect, mitochondrial malfunction, and apoptotic neurodegeneration in Mucopolysaccharidosis VII
Nishan Mandal, Apurba Das, Rupak Datta
Neurobiology of Disease (2025) Vol. 206, pp. 106825-106825
Open Access
Sex Differences in Circulating Inflammatory, Immune, and Tissue Growth Markers Associated with Fabry Disease-Related Cardiomyopathy
Margarita M. Ivanova, Julia Dao, Andrew Friedman, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 322-322
Open Access
Reversing Pathology in an Aggravated Fabry Mouse Model Using Low-Dose Engineered Human Alpha-Galactosidase A AAV Gene Therapy
Wanida Ruangsiriluk, Mugdha Deshpande, Natalia Boukharov, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 577-577
Open Access
Organellar crosstalk as a potential therapeutic target for rare neurodegenerative diseases
Josephine Lam, Chenxu Li, Márcia R. Terluk, et al.
Rare Disease and Orphan Drugs Journal (2025) Vol. 4, Iss. 1
Open Access
Disturbances in mitochondrial quality control and mitochondria-lysosome contact underlie the cerebral cortex and heart damage of mucopolysaccharidosis type II mice
Camila Vieira Pinheiro, Rafael Teixeira Ribeiro, Ana Cristina Roginski, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
Page 1 - Next Page

Scroll to top